Fluvoxamine and the Early Treatment of COVID: What does the data say?

Dr. Christy discusses the latest research on Fluvoxamine for the treatment of COVID-19:

To enlist in a trial go to:
stopcovidtrial.wustl.edu

REFERENCES:
France Observational Study with SSRI/SNRI
https://www.medrxiv.org/conten....t/10.1101/2020.07.09

Sigma 1 Receptor Agonist activity of SSRIs
https://www.researchgate.net/p....ublication/40728854_

CETF summary on Fluvoxamine:
https://www.treatearly.org/promising-drugs

Washington Post Op-Ed about Fluvoxamine:
https://www.washingtonpost.com..../outlook/2021/01/27/